Peter Cicala's Insider Trades & SAST Disclosures

Peter Cicala's most recent trade in Eterna Therapeutics Inc was a trade of 51,485 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Feb. 7, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Eterna Therapeutics Inc
Peter Cicala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2025 51,485 51,485 - - Stock Option (Right to buy)
Eterna Therapeutics Inc
Peter Cicala Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2024 88,946 88,946 - - Stock Option (Right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades